Liminatus Pharma Stock Soars 19.53% on Rebranding

On June 12, 2025, Liminatus Pharma's stock surged by 19.53% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Liminatus Pharma's shares experienced a temporary trading halt due to a volatility trading pause. This measure was taken to control the excessive fluctuations in the stock price, a common practice by exchanges to maintain market stability during periods of high volatility.

Liminatus Pharma, Inc. underwent a corporate name change from IRIS ACQUISITION CORP Common Stock to Liminatus Pharma, Inc. This change was accompanied by a ticker change to LIMN, reflecting the company's strategic shift and rebranding efforts.